Correvio Pharma Corp. Finite-Lived Intangible Assets, Net
Correvio Pharma Corp. had Finite-Lived Intangible Assets, Net of $22.23 million as of 2019-12-31, per its 20-F filed 2020-04-30.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsNet · last filed 2020-04-30
- 2019-12-31: Finite-Lived Intangible Assets, Net $22.23M.
- 2018-12-31: Finite-Lived Intangible Assets, Net $26.47M.
- 2017-12-31: Finite-Lived Intangible Assets, Net $27.81M.
- 2016-12-31: Finite-Lived Intangible Assets, Net $24.35M.
| Period end | Finite-Lived Intangible Assets, Net |
|---|---|
| 2019-12-31 | $22.23M 20-F · filed 2020-04-30 |
| 2018-12-31 | $26.47M 20-F · filed 2020-04-30 |
| 2017-12-31 | $27.81M 40-F · filed 2019-03-13 |
| 2016-12-31 | $24.35M 20-F · filed 2018-04-30 |
| 2015-12-31 | $14.22M 40-F · filed 2017-03-29 |
| 2014-12-31 | $16.16M 40-F · filed 2016-03-29 |
| 2013-12-31 | $18.07M 40-F · filed 2015-03-27 |
| 2012-12-31 | $1.51M 40-F/A · filed 2014-04-30 |
| 2011-12-31 | $1.55M 20-F/A · filed 2013-04-18 |
| 2010-12-31 | $1.64M 40-F/A · filed 2012-04-25 |